Value of ultrasound in assessing response to neoadjuvant chemotherapy in breast cancer

CONCLUSION: This study has shown significance in reducing LD measurements on ultrasound as a predictor of PCR and RCB class. This adds weight to the current practice of using ultrasound at the start, mid and end of chemotherapy cycles to monitor NACT responses.PMID:37734976 | DOI:10.1016/j.crad.2023.07.010

Source: Clinical Breast Cancer - September 21, 2023 Category: Cancer & Oncology Authors: H F Lim A Sharma C Gallagher P Hall Source Type: research